Physician profile
Bipin Joshi
NPI 1336162486
$50,682.10
in general payments reported to CMS, 2019-2025
50 companies · $3,658 in 2025
The $3,658 reported for 2025 was more than what 97% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $8,965 · 2021: $3,721 · 2022: $5,099 · 2023: $5,748 · 2024: $4,380 · 2025: $3,658.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $701 · Travel and Lodging: $409 · Education: $70.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,605.41 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $700.50 |
| Travel and Lodging | $409.42 |
| Education | $70.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $14,043.47 | 2019-2025 | |
| Amgen INC. | $11,024.65 | 2019-2025 | Repatha, Repatha, Tezspire |
| Astrazeneca Pharmaceuticals LP | $4,607.48 | 2019-2025 | Farxiga, Lokelma |
| Abiomed | $3,103.21 | 2019-2025 | Impella |
| E.R. Squibb & Sons, L.L.C. | $1,706.96 | 2019-2025 | Camzyos, Eliquis |
| Medtronic Vascular, INC. | $1,341.60 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,222.94 | 2019-2025 | Jardiance |
| Esperion Therapeutics, INC. | $1,136.60 | 2020-2024 | Nexletol, Nexlizet |
| Janssen Pharmaceuticals, INC | $1,044.05 | 2019-2024 | Xarelto |
| Medtronic, INC. | $819.54 | 2021-2025 | Corevalve Evolut R, Onyx Frontier, Azure Xt Dr Mri Surescan |
| Actelion Pharmaceuticals US, INC. | $803.57 | 2020-2025 | Uptravi, Opsumit, Opsynvi |
| Pfizer INC. | $739.35 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $737.57 | 2021-2025 | Verquvo, Capvaxive |
| Shockwave Medical, INC | $665.28 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Bayer Healthcare Pharmaceuticals INC. | $633.56 | 2022-2025 |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $624.72 | 2019-2025 | Confirm Rx, Gallant, Jot Dx |
| Chiesi USA, INC. | $536.55 | 2019-2024 | Kengreal |
| Novo Nordisk INC | $521.57 | 2023-2025 | |
| Edwards Lifesciences Corporation | $514.55 | 2019-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $486.51 | 2020-2025 | General - Balloon Catheters, Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Alnylam Pharmaceuticals INC. | $486.48 | 2021-2025 | Amvuttra, Onpattro |
| Philips North America LLC | $400.85 | 2025 | Igt Devices Undivided |
| Akcea Therapeutics, INC. | $400.11 | 2019-2021 | |
| Baylis Medical Company INC | $369.56 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $347.07 | 2023-2024 | Inpefa |
| Sanofi-Aventis U.S. LLC | $299.85 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $280.91 | 2021-2023 | Arcalyst |
| Penumbra, INC. | $183.79 | 2021-2022 | |
| Scpharmaceuticals INC. | $182.97 | 2023-2025 | |
| Daiichi Sankyo INC. | $170.00 | 2020-2024 | Injectafer |
| Kowa Pharmaceuticals America, INC. | $143.98 | 2020-2022 | |
| Amarin Pharma, INC. | $124.99 | 2019 | |
| Bridgebio Pharma, INC. | $115.49 | 2025 | Attruby |
| Gilead Sciences, INC. | $112.64 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $100.30 | 2024 | Arcalyst |
| Lilly USA, LLC | $87.00 | 2021-2024 | Mounjaro |
| Cvrx, INC. | $85.83 | 2024 | Barostim Neo System |
| Baxter Healthcare | $69.37 | 2023 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Life 2000 Ventilation System |
| Vifor Pharma, INC. | $67.57 | 2019-2020 | |
| United Therapeutics Corporation | $47.16 | 2019-2021 | |
| Elutia, INC. | $43.49 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $40.08 | 2023 | Evkeeza |
| Inspire Medical Systems, INC. | $38.23 | 2023-2025 | Inspire |
| Biotronik INC. | $37.94 | 2020-2022 | |
| Ionis Pharmaceuticals, INC. | $31.04 | 2025 | Tryngolza |
| Kestra Medical Technology Services, INC. | $28.42 | 2024 | Assure Wcd |
| Astellas Pharma US INC | $23.52 | 2022 | |
| Glaxosmithkline, LLC. | $18.93 | 2025 | Shingrix |
| Avinger INC. | $18.43 | 2021 | |
| Amryt Pharma Holdings LTD | $12.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bipin Joshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.